Picture of Austar Lifesciences logo

6118 Austar Lifesciences Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Austar Lifesciences, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line12.241.531986.5-34.4
Depreciation
Amortisation
Non-Cash Items4.443.13-1920.74155.3
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-5.15-24.3-262-165-129
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities37.852.2-103-37.9-62.6
Capital Expenditures-13.7-26.5-101-117-69.2
Purchase of Fixed Assets
Other Investing Cash Flow Items-8.36-33.3166-35.814.8
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-22.1-59.865-153-54.5
Financing Cash Flow Items-3.35-2.79-4.4-5.19-23.5
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-20.7-5.5159.3125147
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5.38-13.120.5-64.830.1